Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5552740 | 0.84 | — | — | |
| SCHEMBL1887757 | 0.76 | — | — | |
| SCHEMBL3142450 | 0.76 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL2331578 | 0.73 | — | — | |
| SCHEMBL30593075 | 0.73 | — | — | |
| SCHEMBL14989362 | 0.73 | MAPK1 (0.43) | ALDH1A1 | |
| SCHEMBL15296895 | 0.72 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL24856 | 0.65 | — | — | |
| SCHEMBL35239 | 0.65 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL4043457 | 0.62 | ALDH1A1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | DURACELL U.S. OPERATIONS, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-12529006-B2 | Methods of reducing lead corrosion in an internal combustion engine | AFTON CHEMICAL CORPORATION (US) | 2026-01-20 | — | — | US | claimed |
| US-20250215020-A1 | COMPOUNDS AS ELASTASE INHIBITOR AND METHOD OF PREPARING THE SAME | SHANGHAI ARK BIOPHARMACEUTICAL CO. LTD. (CN) | 2025-07-03 | — | — | US | claimed |
| EP-4263676-B1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL INT RESEARCH (NL) | 2024-10-30 | — | — | EP | claimed |
| EP-4263677-B1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL INT RESEARCH (NL) | 2024-10-30 | — | — | EP | claimed |
| US-20240025871-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL USA, INC. | 2024-01-25 | — | — | US | claimed |
| EP-4263677-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | Shell Internationale Research Maatschappij B.V. (NL) | 2023-10-25 | — | — | EP | claimed |
| EP-4263676-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | Shell Internationale Research Maatschappij B.V. (NL) | 2023-10-25 | — | — | EP | claimed |
| US-20230210790-A1 | GEL FOR USE IN GASTROINTESTINAL ENDOSCOPY AND ENDODERMAL, EPIDERMAL, AND OTHER MUCOSAL USES | THE JOHNS HOPKINS UNIVERSTY | 2023-07-06 | — | — | US | claimed |
| US-20230043947-A1 | METHODS OF REDUCING LEAD CORROSION IN AN INTERNAL COMBUSTION ENGINE | AFTON CHEMICAL CORPORATION | 2023-02-09 | — | — | US | claimed |
| EP-2895492-A1 | PROCESS FOR PREPARING OF BORTEZOMIB | Cipla Limited (IN) | 2015-07-22 | — | — | EP | claimed |
| WO-2014041324-A1 | PROCESS FOR PREPARING OF BORTEZAMIB | CIPLA LIMITED (IN) | 2014-03-20 | — | — | WO | claimed |
| US-20130085277-A1 | PROCESS FOR THE PREPARATION OF BORTEZOMIB | RANBAXY LABORATORIES LIMITED (IN) | 2013-04-04 | — | — | US | claimed |
| EP-2534159-A1 | PROCESS FOR THE PREPARATION OF BORTEZOMIB | Ranbaxy Laboratories Limited (IN) | 2012-12-19 | — | — | EP | claimed |
| WO-2011098963-A9 | PROCESS FOR THE PREPARATION OF BORTEZOMIB | RANBAXY LABORATORIES LIMITED (IN) | 2012-01-26 | — | — | WO | claimed |
| EP-2377868-A1 | Synthesis of Bortezomib | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2011-10-19 | — | — | EP | claimed |
| WO-2011098963-A1 | PROCESS FOR THE PREPARATION OF BORTEZOMIB | RANBAXY LABORATORIES LIMITED (IN) | 2011-08-18 | — | — | WO | claimed |
| US-20100226597-A1 | BORTEZOMIB AND PROCESS FOR PRODUCING SAME | DR. REDDY'S LABORATORIES LIMITED (IN) | 2010-09-09 | — | — | US | claimed |
| EP-2185159-A2 | BORTEZOMIB AND PROCESS FOR PRODUCING SAME | Dr. Reddy's Laboratories, Ltd. (IN) | 2010-05-19 | — | — | EP | claimed |
| WO-2009036281-A2 | BORTEZOMIB AND PROCESS FOR PRODUCING SAME | DR. REDDY'S LABORATORIES LTD. (IN) | 2009-03-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | EED, SELE, CTNND1 | ALDH1A1 1624/4885 |
| US-20250215020-A1 | COMPOUNDS AS ELASTASE INHIBITOR AND METHOD OF PREPARING THE SAME | SERPINB1, ELANE, CELA1 | ALDH1A1 2733/4885 |
| US-20100226597-A1 | BORTEZOMIB AND PROCESS FOR PRODUCING SAME | PSMC1, PSMB4, PSMB1 | ALDH1A1 4572/4885 |
| US-12529006-B2 | Methods of reducing lead corrosion in an internal combustion engine | BCKDK, PHKG2, PHKG1 | ALDH1A1 626/4885 |
| US-20130085277-A1 | PROCESS FOR THE PREPARATION OF BORTEZOMIB | PSMB5, PSMB1, PSMC1 | ALDH1A1 3622/4885 |
| US-20230210790-A1 | GEL FOR USE IN GASTROINTESTINAL ENDOSCOPY AND ENDODERMAL, EPIDERMAL, AND OTHER MUCOSAL USES | EPX, EPCAM, ELANE | ALDH1A1 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.